CC
IDYA icon

Commodore Capital’s IDEAYA Biosciences IDYA Stock Holding History

Commodore Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-775,000
Closed -$20.9M – 35
2023
Q3 		$20.9M Hold
775,000
– – 2.44% 15
2023
Q2 		$18.2M Buy
+775,000
New +$15.9M 2.05% 16

Other funds holding IDYA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Commodore Capital's IDYA Position: Q4 2023 in Review

Commodore Capital sold out of IDEAYA Biosciences (IDYA) in Q4 2023, closing a stake of 775,000 shares — an estimated $20.9M sold.

Commodore Capital first reported a position in IDYA in Q2 2023 and held it in 2 quarters. The position peaked at $20.9M in Q3 2023. 157 funds tracked by Wall St. Rank hold IDYA as of Q4 2023.

  • Commodore Capital reported no remaining IDEAYA Biosciences position as of Q4 2023 after selling out during the quarter.
  • Commodore Capital sold 775,000 IDEAYA Biosciences shares in Q4 2023, an estimated $20.9M.
  • Commodore Capital first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 2 quarters.
  • Commodore Capital's IDEAYA Biosciences position peaked at $20.9M in Q3 2023.
  • 157 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2023.

Based on Commodore Capital's 13F filing for Q4 2023, filed 14 Feb 2024.